Edward L. Barnes MD MPH, from the University of North Carolina at Chapel Hill, answers questions about the management of pouchitis in ulcerative colitis, a topic he discussed during his session at the...
In this podcast, Thomas Keller, MD, discusses his analysis on the association of guideline-recommended chronic obstructive pulmonary disease inhaler regimens with mortality, respiratory exacerbations, and...
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
Clifford Rosen, MD, chair of the Endocrine Society's 2019 clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women, reviews key points of the new guideline. ...
The authors of a recent study examined the safety and clinical efficacy of using mepolizumab to treat patients with HES. First author Florence Roufosse, MD, PhD, answered Consultant360’s questions on the...
Generic medications are becoming an increasingly hot topic, as the cost of prescriptions rise. The authors of a recent study sought to examine the attitudes of health care providers on prescribing generic...
International Menopause Society President Susan Davis, PhD, discusses key points from the latest consensus statement on the use of testosterone therapy in women. The statement has been endorsed by various...
In this article, James Matera, DO, writes about the benefits of using SGLT2 inhibitors to treat patients with type 2 diabetes, chronic kidney disease, and cardiovascular disease, including how the use of...
In this Q&A, Marie Bradley, PhD, discusses a recent study in which researchers examined how the benefit risk of apixaban and warfarin varied by age in patients aged less than 65 years with nonvalvular...
In this commentary, Charlotte Owens, MD, reviews data from the American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, including study findings on treatment options for...
